Warning: The NCBI web site requires JavaScript to function. more...
Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
Dlamini SV, Beshir K, Sutherland CJ.
Malar J. 2010 Mar 3;9:68.
Related citations
Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran.
Zakeri S, Afsharpad M, Raeisi A, Djadid ND.
Malar J. 2007 Nov 13;6:148.
Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
Enosse S, Magnussen P, Abacassamo F, Gómez-Olivé X, Rønn AM, Thompson R, Alifrangis M.
Malar J. 2008 Jul 1;7:115.
Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Lekana-Douki JB, Dinzouna Boutamba SD, Zatra R, Zang Edou SE, Ekomy H, Bisvigou U, Toure-Ndouo FS.
Infect Genet Evol. 2011 Mar;11(2):512-7. Epub 2011 Jan 17.
Analysis of genetic mutations associated with anti-malarial drug resistance in Plasmodium falciparum from the Democratic Republic of East Timor.
de Almeida A, Arez AP, Cravo PV, do Rosário VE.
Malar J. 2009 Apr 9;8:59.
Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum.
Osman ME, Mockenhaupt FP, Bienzle U, Elbashir MI, Giha HA.
Infect Genet Evol. 2007 Jan;7(1):52-9. Epub 2006 May 11.
Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola.
Figueiredo P, Benchimol C, Lopes D, Bernardino L, do Rosário VE, Varandas L, Nogueira F.
Malar J. 2008 Nov 17;7:236.
Seasonal distribution of anti-malarial drug resistance alleles on the island of Sumba, Indonesia.
Asih PB, Rogers WO, Susanti AI, Rahmat A, Rozi IE, Kusumaningtyas MA, Krisin, Sekartuti, Dewi RM, Coutrier FN, Sutamihardja A, van der Ven AJ, Sauerwein RW, Syafruddin D.
Malar J. 2009 Sep 29;8:222.
Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.
Marfurt J, Smith TA, Hastings IM, Müller I, Sie A, Oa O, Baisor M, Reeder JC, Beck HP, Genton B.
Malar J. 2010 Jan 7;9:8.
Detection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern Ethiopia.
Mula P, Fernández-Martínez A, de Lucio A, Ramos JM, Reyes F, González V, Benito A, Berzosa P.
Malar J. 2011 Aug 2;10:214.
Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications.
Mubjer RA, Adeel AA, Chance ML, Hassan AA.
Malar J. 2011 Aug 21;10:245.
Association of pfcrt but not pfmdr1 alleles with chloroquine resistance in Iranian isolates of Plasmodium falciparum.
Zakeri S, Afsharpad M, Kazemzadeh T, Mehdizadeh K, Shabani A, Djadid ND.
Am J Trop Med Hyg. 2008 Apr;78(4):633-40.
High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.
Schunk M, Kumma WP, Miranda IB, Osman ME, Roewer S, Alano A, Löscher T, Bienzle U, Mockenhaupt FP.
Malar J. 2006 Jul 3;5:54.
Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.
Ojurongbe O, Ogungbamigbe TO, Fagbenro-Beyioku AF, Fendel R, Kremsner PG, Kun JF.
Malar J. 2007 Apr 11;6:41.
Nonradioactive heteroduplex tracking assay for the detection of minority-variant chloroquine-resistant Plasmodium falciparum in Madagascar.
Juliano JJ, Randrianarivelojosia M, Ramarosandratana B, Ariey F, Mwapasa V, Meshnick SR.
Malar J. 2009 Mar 16;8:47.
Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.
Alam MT, de Souza DK, Vinayak S, Griffing SM, Poe AC, Duah NO, Ghansah A, Asamoa K, Slutsker L, Wilson MD, Barnwell JW, Udhayakumar V, Koram KA.
J Infect Dis. 2011 Jan 15;203(2):220-7.
Plasmodium falciparum pfcrt and pfmdr1 polymorphisms are associated with the pfdhfr N108 pyrimethamine-resistance mutation in isolates from Ghana.
Mockenhaupt FP, Eggelte TA, Till H, Bienzle U.
Trop Med Int Health. 2001 Oct;6(10):749-55.
Chloroquine resistance before and after its withdrawal in Kenya.
Mwai L, Ochong E, Abdirahman A, Kiara SM, Ward S, Kokwaro G, Sasi P, Marsh K, Borrmann S, Mackinnon M, Nzila A.
Malar J. 2009 May 18;8:106.
Molecular epidemiology of drug-resistant malaria in western Kenya highlands.
Zhong D, Afrane Y, Githeko A, Cui L, Menge DM, Yan G.
BMC Infect Dis. 2008 Jul 31;8:105.
Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic.
Menard D, Djalle D, Yapou F, Manirakiza A, Talarmin A.
Am J Trop Med Hyg. 2006 Feb;74(2):205-10. Erratum in: Am J Trop Med Hyg. 2006 Mar;74(3):516.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on